Home/Filings/4/0001209191-14-012068
4//SEC Filing

NANOMETRICS INC 4

Accession 0001209191-14-012068

$ONTOCIK 0000704532operating

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 8:20 PM ET

Size

34.5 KB

Accession

0001209191-14-012068

Insider Transaction Report

Form 4
Period: 2014-02-14
Crawford Bruce A
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    2014-02-14$18.63/sh14,686$273,60042,525 total
  • Tax Payment

    Common Stock

    2014-02-17$18.70/sh1,388$25,95641,137 total
  • Exercise/Conversion

    Common Stock

    2014-02-18$7.50/sh+3,443$25,82346,247 total
  • Sale

    Common Stock

    2014-02-18$18.52/sh26,278$486,66933,264 total
  • Exercise/Conversion

    Common Stock

    2014-02-19$15.85/sh+3,333$52,82837,157 total
  • Sale

    Common Stock

    2014-02-19$18.42/sh3,893$71,70933,264 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2014-02-1812,5000 total
    Exercise: $13.08Exp: 2016-11-17Common Stock (12,500 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2014-02-1956016,250 total
    Exercise: $11.37Exp: 2017-11-15Common Stock (560 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-18$1.17/sh+1,667$1,95042,804 total
  • Exercise/Conversion

    Common Stock

    2014-02-18$11.37/sh+795$9,03959,542 total
  • Exercise/Conversion

    Common Stock

    2014-02-19$11.37/sh+560$6,36733,824 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2014-02-183,4430 total
    Exercise: $7.50Exp: 2016-09-03Common Stock (3,443 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2014-02-1879516,810 total
    Exercise: $11.37Exp: 2017-11-15Common Stock (795 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2014-02-193,33316,667 total
    Exercise: $15.85Exp: 2020-03-12Common Stock (3,333 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-18$13.08/sh+12,500$163,50058,747 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    2014-02-181,6670 total
    Exercise: $1.17Exp: 2016-02-25Common Stock (1,667 underlying)
Footnotes (10)
  • [F1]Transaction pursuant to Rule 10b5-1 Plan adopted December 13, 2013.
  • [F10]One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (March 12, 2013).
  • [F2]Represents weighted average sales price. The shares were sold at prices ranging from $18.45 to $18.84. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F3]Represents weighted average sales price. The shares were sold at prices ranging from $18.40 to $18.70. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F4]Represents weighted average sales price. The shares were sold at prices ranging from $18.28 to $18.58. The Reporting Person will provide upon request, to the SEC, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
  • [F5]One thirty-sixth (1/36th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (February 25, 2009).
  • [F6]One third (1/3rd) of the shares are fully vested on the date of grant, with the remaining shares vesting (starting on the one year anniversary of the date of grant) at a rate of one twenty-fourth (1/24th) per month until fully vested on September 3, 2012.
  • [F7]One thirty-sixth (1/36th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 17, 2009).
  • [F8]One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 16, 2010).
  • [F9]One forty-eighth (1/48th) of the shares shall vest and become exercisable in equal monthly installments starting on the monthly anniversary of the date of grant (November 16, 2010).

Issuer

NANOMETRICS INC

CIK 0000704532

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000704532

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:20 PM ET
Size
34.5 KB